India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

Raymond's consolidated net profit tumbled 61.01% to Rs 72.28 crore in Q3 FY25 as against Rs 185.39 crore posted in Q3 FY24.

The broader market pulled back from its highs, with the BSE Midcap index up 0.4 percent and the BSE Smallcap index rising 0.7 percent.

The largest chunk of deals for Penspen came from the Middle East and Africa Region, where the company won a total of 26 new ...

Cyprus saw a substantial increase in loans in December 2024, with a rise of €503.2 million following a decrease the previous ...